CAPR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Capricor Therapeutics Inc

Watchlist Manager

Watchlist

Price: 19.7 USD -0.66% Market Closed

Market Cap: $1.1B

	Capricor Therapeutics Inc NASDAQ:CAPR	US
W	Woodward Inc SWB:WW1	US
S	Sailfish Royalty Corp XTSX:FISH	VG
C	Carlisle Companies Inc F:CLE	US
S	Scansource Inc SWB:SC3	US
	Varonis Systems Inc NASDAQ:VRNS	US
	Onemednet Corp NASDAQ:ONMD	UK
T	Teixeira Duarte SA XMUN:TXC2	PT
	Relx PLC LSE:REL	UK
	Atkinsrealis Group Inc F:LAV0	CA
L	Longfor Group Holdings Ltd XMUN:RLF	CN
	Capitaland Investment Ltd F:5NU	SG
	SSE PLC F:SCTA	UK
U	United Tractors Tbk PT XMUN:UTY	ID

Profitability Summary

Capricor Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-267%

Low Net Margin

Negative 3Y Average Net Margin

-270%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-241%

Negative ROE

-47%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-990%

ROIC is Increasing

-935% > -461%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.